Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Merck’s Acquisition of Eyebiotech
Related Argent’s Joint Venture with NTT UD Europe Limited
Gibson, Dunn & Crutcher advised Related Argent on the transaction. Related Argent announced its joint venture with NTT UD Europe Limited, a subsidiary of leading Japanese...
Ansell’s $640 Million Acquisition of KCPPE
Gibson, Dunn & Crutcher is advising Kimberly-Clark Corporation on the transaction. Ansell announced it has entered into a binding agreement to acquire 100% of the assets...